SEC Form 4 · accession 0001654954-18-002443
Cellular Biomedicine Group, Inc. · CBMG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bosun Hau
Director
Period of report
Feb 6, 2018
Accepted (ET)
Mar 13, 2018 · 12:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001378624
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) (2014 Plan) | $19.35 | Feb 6, 2018 | A | 285 | A | Apr 27, 2018 | Feb 6, 2028 | Common Stock | 285 | 285 | D |